We are live on
!
Find out more
Dr. Reddy's Laboratories
125 hedge funds and large institutions have $651M invested in Dr. Reddy's Laboratories in 2018 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 42 increasing their positions, 39 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
154% more call options, than puts
Call options by funds: $650K | Put options by funds: $256K
8% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 39
1% less capital invested
Capital invested by funds: $655M → $651M (-$4.16M)
4.31% less ownership
Funds ownership: 61.26% → 56.95% (-4.3%)
9% less funds holding
Funds holding: 137 → 125 (-12)
36% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 33
Holders
125
Holders Change
-12
Holders Change %
-8.76%
% of All Funds
2.86%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
21
Increased
42
Reduced
39
Closed
33
Calls
$650K
Puts
$256K
Net Calls
+$394K
Net Calls Change
+$917K
Top Buyers
| 1 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
+$11.6M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$7.02M |
| 3 |
Renaissance Technologies
New York
|
+$7M |
| 4 |
BlackRock
New York
|
+$5.87M |
| 5 |
SGA
Sector Gamma AS
Oslo,
Norway
|
+$5.72M |
Top Sellers
| 1 |
MWNA
Marshall Wace North America
New York
|
-$16.7M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$9.21M |
| 3 |
Two Sigma Investments
New York
|
-$8.84M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$8.54M |
| 5 |
Goldman Sachs
New York
|
-$8.01M |
